Over the past several years, single-nucleotide polymorphisms (SNPs) within the mprF open reading frame (ORF) have been proposed to be associated with a gain-of-function phenotype in terms of daptomycin (DAP) nonsusceptibility (referred to as daptomycin resistance [DAP-R] herein for ease of presentation) in Staphylococcus aureus. We investigated the frequencies of SNPs within the mprF ORF and the relationships of such SNPs to cross-resistance between DAP and cationic host defense peptides (HDPs). Thirty-five well-characterized, unique DAP-susceptible (DAP-S) and DAP-R methicillin-resistant S. aureus (MRSA) isolates of the clonal complex 5 genotype were used. In addition to mprF SNPs and DAP-HDP cross-resistance, several other key genotypic a...
ABSTRACT Daptomycin, a calcium-dependent lipopeptide antibiotic whose full mode of action is still n...
The mechanisms leading to reduced susceptibility to daptomycin (DAP) are multifactorial and have not...
The mechanisms leading to reduced susceptibility to daptomycin (DAP) are multifactorial and have not...
Over the past several years, single-nucleotide polymorphisms (SNPs) within themprF open reading fram...
Daptomycin (DAP) is one of the most potent antibiotics used for the treatment of methicillin-resista...
Development of in vivo daptomycin resistance (DAP-R) among Staphylococcus aureus clinical isolates, ...
Development of in vivo daptomycin resistance (DAP-R) among Staphylococcus aureus clinical isolates, ...
Development of in vivo daptomycin resistance (DAP-R) among Staphylococcus aureus clinical isolates, ...
Development of in vivo daptomycin resistance (DAP-R) among Staphylococcus aureus clinical isolates, ...
<div><p>Development of <i>in vivo</i> daptomycin resistance (DAP-R) among <i>Staphylococcus aureus</...
Using isogenic clinical bloodstream Staphylococcus aureus strains from a patient with relapsing endo...
BackgroundPrevious studies of both clinically-derived and in vitro passage-derived daptomycin-resist...
BackgroundPrevious studies of both clinically-derived and in vitro passage-derived daptomycin-resist...
Previous studies of both clinically-derived and in vitro passage-derived daptomycin-resistant (DAP-R...
Objectives: Daptomycin (DAP) resistance in Staphylococcus aureus is uncommon but there are increasin...
ABSTRACT Daptomycin, a calcium-dependent lipopeptide antibiotic whose full mode of action is still n...
The mechanisms leading to reduced susceptibility to daptomycin (DAP) are multifactorial and have not...
The mechanisms leading to reduced susceptibility to daptomycin (DAP) are multifactorial and have not...
Over the past several years, single-nucleotide polymorphisms (SNPs) within themprF open reading fram...
Daptomycin (DAP) is one of the most potent antibiotics used for the treatment of methicillin-resista...
Development of in vivo daptomycin resistance (DAP-R) among Staphylococcus aureus clinical isolates, ...
Development of in vivo daptomycin resistance (DAP-R) among Staphylococcus aureus clinical isolates, ...
Development of in vivo daptomycin resistance (DAP-R) among Staphylococcus aureus clinical isolates, ...
Development of in vivo daptomycin resistance (DAP-R) among Staphylococcus aureus clinical isolates, ...
<div><p>Development of <i>in vivo</i> daptomycin resistance (DAP-R) among <i>Staphylococcus aureus</...
Using isogenic clinical bloodstream Staphylococcus aureus strains from a patient with relapsing endo...
BackgroundPrevious studies of both clinically-derived and in vitro passage-derived daptomycin-resist...
BackgroundPrevious studies of both clinically-derived and in vitro passage-derived daptomycin-resist...
Previous studies of both clinically-derived and in vitro passage-derived daptomycin-resistant (DAP-R...
Objectives: Daptomycin (DAP) resistance in Staphylococcus aureus is uncommon but there are increasin...
ABSTRACT Daptomycin, a calcium-dependent lipopeptide antibiotic whose full mode of action is still n...
The mechanisms leading to reduced susceptibility to daptomycin (DAP) are multifactorial and have not...
The mechanisms leading to reduced susceptibility to daptomycin (DAP) are multifactorial and have not...